Odonate Therapeutics Overview
Latest P/E ratio for Odonate Therapeutics: 3227.62 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow3227.62
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for ODT is 3227.62. That is above the Healthcare sector average of 27.42. Investors often review this figure alongside Odonate Therapeutics's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, ODT currently prints 3227.62 for P/E ratio, while the sector average sits near 27.42. That is roughly 11669.1% above the sector mean. Large gaps often invite a closer look at Odonate Therapeutics's growth, margins, and balance sheet.
A P/E ratio of 3227.62 for Odonate Therapeutics is not 'good' or 'bad' on its own. Compare it with the peer average (27.42) and with ODT's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting ODT's P/E ratio (3227.62), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Odonate Therapeutics's P/E ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
